image_alt_text
2

Fellowbook News

AIMBE Fellowbook collects news stories highlighting the members of the AIMBE College of Fellows. Read the latest stories, jump to the College Directory, or search below to find the newest research, awards, announcements and more for the leaders of the medical and biological engineering community.

 

 

Stryker Creates Chief Scientist Position, Hires Bruder

Scott Bruder | Via Orthopedics This Week | January 8, 2013

Scott Bruder, M.D., Ph.D. has been a professor of biomedical engineering, an FDA Advisory Panel member, chief science and technology officer and a seasoned science executive with Becton, Dickinson and Company, DePuy, Inc., Anika Therapeutics, Inc. and Osiris Therapeutics, Inc. The new leaders at Stryker Corporation took notice and convinced Bruder to fill a new […]

Wheeler Steps Down as TBME Editor in Chief

Bruce Wheeler | Via University of Florida | January 8, 2013

Bruce Wheeler, the Editor in Chief of the IEEE Transactions on Biomedical Engineering (TBME), completes his second term on December 31, 2012. His successor is Dr. Bin He of the University of Minnesota. Dr. Wheeler succeeded Dr. Jose Principe, of the UF Electrical and Computer Engineering Department, whose term ran from 2001 through 2006. Dr. […]

Stryker Announces Appointment of Scott Bruder, MD, PhD to the Position of Vice President, Chief Medical and Scientific Officer

Scott Bruder | Via Bioscience Technology | January 7, 2013

Stryker Corporation (NYSE:SYK) announced that Scott P. Bruder, MD, PhD has joined the Company in the newly created position of Vice President, Chief Medical and Scientific Officer, reporting to Kevin A. Lobo, President and Chief Executive Officer.  In this role, Dr. Bruder will oversee the clinical and scientific efforts of Stryker Corporation, including academic, industrial […]

Immucor Acquires Hologic’s Lifecodes Division for $85 Million

William Hawkins | Via Qmed | January 7, 2013

Immucor, a healthcare products company based in Norcross, Georgia, announced that it would acquire Hologics’ Lifecodes division for $85 million. According to a press release by the company, the new acquisition could be worth up to $95 million if Hologic meets certain financial milestones. This is Immucor’s first acquisition since CEO William Hawkins (previously CEO […]

Two MIT Professors Win Prestigious Wolf Prize

Robert Langer | Via Massachusetts Institute of Technology | January 4, 2013

MIT professors Michael Artin and Robert Langer are among eight recipients worldwide of the 2013 Wolf Prize, the Israel-based Wolf Foundation announced this week. The prestigious international prizes are awarded annually in five categories, each worth $100,000; Artin and Langer were cited for their contributions in mathematics and chemistry, respectively. More than 30 Wolf Prize […]

UCSD Study Clarifies Epigenetic Behavior

Trey Ideker | Via UT San Diego | January 4, 2013

UC San Diego researchers have dashed the hopes of scientists looking for an easy way to determine how genes are turned off and on by regulatory chemicals, a field known as epigenetics. The genes interact with histones, proteins that surround DNA, and also with other epigenetic factors. Where the genes are placed in the DNA […]

In Epigenomics, Location is Everything: Researchers exploit gene position to test “histone code”

Trey Ideker | Via UC San Diego News | January 3, 2013

In a novel use of gene knockout technology, researchers at the University of California, San Diego School of Medicine tested the same gene inserted into 90 different locations in a yeast chromosome – and discovered that while the inserted gene never altered its surrounding chromatin landscape, differences in that immediate landscape measurably affected gene activity.  […]

Interview with Mark Tracy: Insights into the Biopharmaceutical Industry

Mark Tracy | Via Controlled Release Society | January 1, 2013

Dr. Mark Tracy served as president of the Controlled Release Society (CRS) from 2010 to 2011 and on its Board of Directors (BOD) from 2008 to 2012. He also served on the CRS Board of Scientific Advisors from 2002 to 2005 and was a cochair for the CRS Annual Meeting in New York City in […]

Rensselaer Researchers Delve Into Osteocalcin

Deepak Vashishth | Via Orthopedics This Week | December 21, 2012

A team from Rensselaer Polytechnic Institute has found—for the first time—how the protein osteocalcin plays a significant role in the strength of our bones. The findings could lead to new strategies and therapeutics for fighting osteoporosis and lowering the risk of bone fracture. This work, led by Deepak Vashishth, Ph.D., head of the Department of […]

Chisholm, Langer Awarded Nation’s Highest Honors for Scientists and Inventors

Robert Langer | Via Massachusetts Institute of Technology | December 21, 2012

MIT professors Sallie (Penny) Chisholm and Robert Langer are among 23 eminent researchers nationwide who have been awarded the nation’s highest honors for scientists, engineers and inventors, the White House announced today. President Barack Obama will present the National Medal of Science to Chisholm, the Lee and Geraldine Martin Professor of Environmental Studies in MIT’s […]

Waste not, Want not: Researchers Convert Soybeans to Important Chemical

George N. Bennett | Via Knovel | December 21, 2012

For most environmentalists, the biggest focus in recent years has been the effort to switch from fossil fuels to renewable energy sources, but hydrocarbons like oil and gas go to more than just energy. One engineering research team at Rice University believes that it has found a way to replace petroleum with a renewable crop, […]

Waste Not, Want Not: Researchers Convert Soybeans to Important Chemical

Ka-Yiu San | Via Knovel | December 21, 2012

For most environmentalists, the biggest focus in recent years has been the effort to switch from fossil fuels to renewable energy sources, but hydrocarbons like oil and gas go to more than just energy. One engineering research team at Rice University believes that it has found a way to replace petroleum with a renewable crop, […]

Soybeans a Source of Valuable Chemical

Ka-Yiu San | Via Rice University News | December 19, 2012

Rice University scientists turn low-value soy mash into high-value succinic acid The humble soybean could become an inexpensive new source of a widely used chemical for plastics, textiles, drugs, solvents and as a food additive. Indigestible byproducts of soybeans can be turned into valuable succinic acid through a process developed at Rice University. Succinic acid, traditionally drawn […]

Soybeans a Source of Valuable Chemical

George N. Bennett | Via Rice University News | December 19, 2012

The humble soybean could become an inexpensive new source of a widely used chemical for plastics, textiles, drugs, solvents and as a food additive. Succinic acid, traditionally drawn from petroleum, is one focus of research by Rice chemists George Bennett and Ka-Yiu San. In 2004, the Department of Energy named succinic acid one of 12 “platform” chemicals […]

National Academy of Inventors Names Four UT Arlington Professors as Charter Fellows

Khosrow Behbehani | Via University of Texas at Arlington | December 19, 2012

Four University of Texas at Arlington engineering professors have been named charter fellows to the National Academy of Inventors.   They are Khosrow Behbehani, professor and chair of the Bioengineering Department; Nai Yuen Chen, a National Academy of Engineering member and distinguished research professor in the Materials Science and Engineering Department; George Kondraske, electrical engineering […]

Autoimmune disease – Retraining White Blood Cells

Jeffrey Hubbell | Via École Polytechnique Fédérale De Lausanne | December 18, 2012

Engineering antigens for in situ erythrocyte binding induces T-cell deletion. “Antigens derived from apoptotic cell debris can drive clonal T-cell deletion or anergy, and antigens chemically coupled ex vivo to apoptotic cell surfaces have been shown correspondingly to induce tolerance on infusion. Reasoning that a large number of erythrocytes become apoptotic (eryptotic) and are cleared […]

Autoimmune Disease – Retraining White Blood Cells

Jeffrey Hubbell | Via École Polytechnique Fédérale De Lausanne | December 18, 2012

Symptoms of an autoimmune disease disappeared after a team of scientists retrained white blood cells using a specially engineered protein. This method is extremely promising for treating diseases such as type I diabetes and multiple sclerosis. How can the immune system be reprogrammed once it starts to attack its own body? EPFL scientists retrained white […]

Toward a New Model of the Cell: Everything You Always Wanted to Know About Genes

Trey Ideker | Via UC San Diego | December 17, 2012

Turning vast amounts of genomic data into meaningful information about the cell is the great challenge of bioinformatics, with major implications for human biology and medicine. Researchers at the University of California, San Diego School of Medicine and colleagues have proposed a new method that creates a computational model of the cell from large networks […]

Jellyfish-Inspired Tentacles Capture Cancer

Jeffrey Karp | Via Discovery News | December 13, 2012

Scientists build a device with long strands of DNA tied to a microchip that floats in bloodstream. Tiny strands of DNA that float like jellyfish tentacles can grab and hold tumor cells in the bloodstream in a device inspired by nature that may help cancer patients fight the dreaded disease. The device can be used […]

Angel Medical Systems CEO Dr. David R. Fischell wins Ernst & Young Entrepreneur Of The Year® Award

David Fischell | Via Angel Med | December 13, 2012

Angel Medical Systems, Inc., a privately held medical device company developing implantable technologies for heart attack detection and patient alerting, announced today that its CEO, Dr. David R. Fischell was selected as the Ernst & Young Entrepreneur of the Year 2013 NJ Regional Award winner in Biotechnology and Medical Technology. Finalists were selected by a […]